Journal of Histochemistry and Cytochemistry, Vol. 51, 1201-1206, September 2003, Copyright © 2003, The Histochemical Society, Inc.


ARTICLE

Triple Immunofluorolabeling with Two Rabbit Polyclonal Antibodies and a Mouse Monoclonal Antibody Allowing Three-dimensional Analysis of Cotton Wool Plaques in Alzheimer Disease

Toshiki Uchiharaa, Ayako Nakamuraa, Hiroshi Nakayamac, Kunimasa Arimad, Norio Ishizukab, Hiroshi Morie, and Setsuo Mizushimaf
a Departments of Neuropathology, Tokyo Metropolitan Institute for Neuroscience, Tokyo, Japan
b Brain Structure, Tokyo Metropolitan Institute for Neuroscience, Tokyo, Japan
c Department of Psychiatry, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan
d Department of Laboratory Medicine, National Center Hospital for Mental, Nervous, and Muscular Disorders, National Center for Neurology and Psychiatry, Tokyo, Japan
e Department of Neuroscience, Osaka City University School of Medicine, Osaka, Japan
f Mizushima Clinic, Tokyo, Japan

Correspondence to: Toshiki Uchihara, Dept. of Neuropathology, Tokyo Metropolitan Institute for Neuroscience, 2-6 Musashi-dai, Fuchu, Tokyo 183-8526, Japan. E-mail: uchihara@tmin.ac.jp


  Summary
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

We established a triple-labeling method with two rabbit polyclonal antibodies and a mouse monoclonal antibody and examined autopsied brain tissue with cotton wool plaques (CWPs). One of the polyclonal antibodies was so diluted (anti-Aß42 or anti-Aß40/1:30,000 or anti-von Willebrand factor/1:1000) that its visualization was possible only after amplification with the catalyzed reporter deposition (CARD) method. The other polyclonal antibody (anti-Aß40 or anti-Aß42/1:1000) was visualized with a fluorochrome conjugated to an anti-rabbit antibody that specifically visualized the latter polyclonal antibody because of its lower sensitivity. A monoclonal antibody, AT8, was superimposed to yield triple immunofluorolabeling. Serial optical sections with an interval of 0.3 µm were reconstructed to allow three-dimensional (3D) observation of these three epitopes. Aß40 was localized to core-like structures, mainly in layers I–III, and was sometimes in contact with the vascular wall, both without neuritic reactions. CWPs, present in layers I–VI, were labeled with anti-Aß42 and were accompanied by neuritic reactions. These differences suggest that mechanisms of Aß deposition and its relation to neuritic reactions or to blood vessels differ according to the lesion, even in the same microscopic field.

(J Histochem Cytochem 51:1201–1206, 2003)

Key Words: triple immunofluorescence, three dimensions, reconstruction, laser confocal microscopy, amyloid, Aß42, cotton wool plaques


  Introduction
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

THE COTTON WOOL PLAQUE (CWP) is a peculiar type of senile plaque seen in brains of some patients with familial Alzheimer disease (AD) and in those of sporadic AD. CWPs are characterized by robust deposition of amyloid ß protein (Aß), Aß42 (Crook et al. 1998 ; Le et al. 2001 ; Steiner et al. 2001 ; Verkkoniemi et al. 2001 ; Tabira et al. 2002 ), a longer molecular species of Aß, possibly involved in early phase of Aß deposition (Iwatsubo et al. 1994 ). Although its shorter counterpart Aß40 is also another major constituent of senile plaques, the spatial relationship between these Aß species and other components is of particular interest because deposition of each Aß species is considered to occur at different stages of senile plaque formation (Iwatsubo et al. 1994 ). By immunizing rabbits, one of the authors (HM) has generated anti-Aß antibodies, each of which specifically reacts with either Aß42 or Aß40 (Akiyama et al. 1997 ). We wanted to examine the spatial relationship between these two epitopes specifically detectable with these antibodies by using multi-labeling immunohistochemistry (Van der Loos et al. 1989 ; Uchihara et al. 1995 , Uchihara et al. 2000 ).

One of the obstacles was that the antibodies to be applied on the same sections were from the same species, which usually hampers multilabeling. Several procedures have been proposed to circumvent this difficulty, with some success. For example, conjugation of enzyme, biotin, or fluorochrome to one of the primary antibodies allows separate detection of the two antibodies, but it requires a relatively large amount of the antibody and the conjugation procedure can be cumbersome (Van der Loos et al. 1989 ; Uchihara et al. 1995 ). Another approach is to wash out the bound antibodies with glycine buffer at very low pH after the first cycle of immunodetection (Nakane 1968 ). Treatment in a microwave oven after the color development of the first primary antibody has been reported to be effective in avoiding crossreaction (Lan et al. 1995 ). Although these sequential procedures are generally successful in detecting non-co-localizing epitopes, they are not applicable for multiple immunofluorescence labeling.

A previous study demonstrated that double immunofluorolabeling with two antibodies from the same species was possible with extensive blockade with F(ab')2 fragment (Lewis-Carl et al. 1993 ) between the two primary antibodies. However, double labeling with this method was associated with a significant decrease in the sensitivity of one of the primary antibodies applied after this extensive blocking. This trade-off of double labeling with decreased sensitivity was circumvented when one of the antibodies was amplified (Hunyady et al. 1996 ) with the catalyzed reporter amplification method (CARD). CARD amplification is mediated by the horseradish peroxidase (HRP) on the secondary antibody that catalyzes the activation of tyrosine bound to biotin (Bobrow et al. 1989 ). The activated tyrosine becomes attached to proteins in the tissue section at the site of the antigen–antibody reaction. Biotin bound to tyrosine can then be visualized (Adams 1992 ). With this method, discrimination of the two epitopes is possible based on the different sensitivity of the immunodetection systems either with or without the amplification. The first antibody to be used must be diluted below the level detectable with standard secondary antibody labeled with fluorochrome, but above the level detectable with CARD amplification (Hunyady et al. 1996 ). In the present study we used two different polyclonal antibodies produced in rabbits to visualize two different epitopes possibly co-localizing with each other on the same structure, Aß40/Aß42, and Aß40/von Willebrand factor (a specific marker for vascular endothelial cells). The third antibody, AT8, a mouse monoclonal antibody (MAb) against paired helical filaments (PHFs), major components of neurofibrillary tangles and neurites (Mercken et al. 1992 ), can be combined by using a differently labeled secondary antibody specific for mouse IgG without danger of crossreaction with these polyclonal antibodies.

In observing structures, such as senile plaques, that exceed the thickness (5–10 µm) of routine histological sections, we are not sure whether or not portions included in the section under observation represent the entire structure. We therefore obtained serial optical sections under a laser scanning confocal microscope to be reconstructed for 3D observation. Three-dimensional reconstruction of triple-labeled sections, as we established in this study, can provide an opportunity to observe the entire structure of CWPs and the spatial relationship between the relevant structures.


  Materials and Methods
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

A dementia patient with a familial background of Alzheimer disease was diagnosed with AD based on the presence of many senile plaques and neurofibrillary tangles. Senile plaques in this case were not clearly detectable with the Bodian method, but hematoxylin and eosin staining visualized the cotton wool feature of the plaques without a core. In addition, a core-like structure and perivascular deposits of Aß were observed (Nakayama et al. 2001 ; Tabira et al. 2002 ). The genetic abnormality associated with this phenotype remains to be clarified.

We first undertook experiments to establish the optimal concentrations of the antibodies for the methods used, especially the dilution of the primary antibodies visualized with the CARD method but undetectable by the standard method without CARD amplification. The list of primary antibodies is provided in Table 1. Three-µm-thick mirror sections were obtained from formalin-fixed, paraffin-embedded blocks from the occipital lobe of this patient. Deparaffinized sections were treated with formic acid (>99%) for 5 min to enhance Aß-like immunoreactivity (Kitamoto et al. 1987 ). After being treated with 2% H2O2 and incubation with 5% bovine serum albumin in PBS, sections were incubated at 4C for 2 days with different concentrations (1:1000–1:100,000) of anti-Aß40 or anti-Aß42 antibody (Akiyama et al. 1997 ). One of the mirror sections was visualized after amplification with CARD as previously described (Bobrow et al. 1989 ; Adams 1992 ; Uchihara et al. 2000 ). Briefly, after application of an anti-rabbit IgG made in goat conjugated to horseradish peroxidase (HRP, 1:500; Pierce, Rockford, IL), the HRP signal was amplified with biotinylated tyramide (1:1000; Perkin–Elmer, Boston, MA) and was finally visualized with FITC conjugated to streptavidin (1:200; Vector, Burlingame, CA; Uchihara et al. 2000 ). The counterpart of the mirror section was visualized with anti-rabbit IgG made in goat conjugated with FITC (1:200; Vector).


 
View this table:
[in this window]
[in a new window]
 
Table 1. Antibodies and optimal dilutions used in this study

For triple immunofluorolabeling, deparaffinized sections were similarly subjected to immunolabeling with CARD amplification with one of the polyclonal antibodies made in rabbits (anti-Aß42 1:30,000; anti-Aß40 1:30,000; or anti-von Willebrand factor 1:1000; DAKO, Glostrup, Denmark) as described above and finally visualized to Cy5 conjugated to streptavidin (1:200; Kirkegaard & Perry, Gaithersburg, MD). von Willebrand factor is a marker for vascular endothelial cells and the anti-von Willebrand factor antibody immunolabels blood vessels (Uchihara et al. 1995 ). The sections were then incubated with a mixture of AT8 (1:1000; mouse monoclonal antibody against PHFs; Innogenetics, Zwijndrecht, Belgium) and another polyclonal antibody (anti-Aß40 or anti-Aß42 1:1000) at 4C for another 2 days in the dark. These two antibodies were visualized with a mixture of anti-mouse IgG made in sheep conjugated with rhodamine (1:200; Jackson ImmunoResearch, West Grove, PA) and anti-rabbit IgG made in goat conjugated with FITC (1:200; Vector), respectively.

For 3D observation, formalin-fixed blocks were washed in PBS and cryoprotected by being soaked in 20% sucrose buffered with 0.1 M phosphate. Thick floating sections (50–100-µm in thickness) were obtained on a freezing microtome. They were subjected to the triple-immunolabeling method as above with prolonged incubation (up to 7 days) with the primary antibody. Sections were mounted with 90% glycerol in 0.1 M phosphate buffer containing 0.1% of p-phenylenediamine and were observed under a confocal laser scanning microscope (Leica TCS/SP; Heidelberg, Germany). Excitation of the fluorochromes and their maximal detection wavelength are summarized in Table 2. Serial optical sections were obtained and reconstructed for 3D analysis on software (TRI/3D; Ratoc System, Tokyo, Japan).


 
View this table:
[in this window]
[in a new window]
 
Table 2. Fluorescent dyes and their link to epitopes


  Results
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Serial dilution of one of the polyclonal antibodies (anti-Aß40) demonstrated that the usual immunofluorescence method without CARD amplification (Fig 1A, Fig 1C, Fig 1E, and Fig 1G) requires a high concentration of the antibody (1:1000) to obtain maximal labeling (Fig 1C). However, CARD amplification (Fig 1B, Fig 1D, Fig 1F, and Fig 1H) enabled us to use the antibody at lower concentrations (up to 1:30,000) to obtain a clear fluorescent signal of an equivalent intensity with little background staining (Fig 1F). Omission of either primary antibody, secondary antibody, or biotinylated tyramide completely eliminated the immunofluorescent signal. Similar results were obtained with the anti-Aß42 antibody (data not shown).



View larger version (54K):
[in this window]
[in a new window]
 
Figure 1. Immunolabeling of mirror-section pairs from cerebral cortex with anti-Aß40 at dilution 1:1000 (A,B), 1:10,000 (C,D), 1:30,000 (E,F), and 1:100,000 (G,H) visualized without (A,C,E,G) and with (B,D,F,H) CARD amplification. At dilution 1:30,000, labeling after CARD amplification visualized Aß40 deposits (F), but that without the amplification failed to exhibit labeling (E). Bar = 100 µm.

Therefore, we first performed CARD-amplified immunofluorolabeling with anti-Aß40 (Fig 2A–2C), which was visualized with Cy5, shown as blue. Subsequent double labeling with AT8 (1:1000; Fig 2A–2C, red) and with anti-Aß42 (1:1000; Fig 2A and Fig 2C, green) antibody was visualized with the mixture of anti-mouse IgG conjugated with rhodamine and anti-rabbit IgG conjugated with FITC. As shown in Fig 2, no crossreaction between the two rabbit polyclonal antibodies (anti-Aß40 and anti-Aß42) was detectable. Moreover, it is noteworthy that reverse experiments, anti-Aß42 with amplification followed by anti-Aß40, gave essentially the same results (Fig 3).



View larger version (114K):
[in this window]
[in a new window]
 
Figure 2. (A) Cerebral cortex (pial surface, right upper corner; white matter, left lower corner) immunofluorolabeled with anti-Aß42 (green), anti-Aß40 (blue), and anti-PHF (red). Large deposits of Aß42 are scattered without specific laminar distribution. (B) The same field as A. Immunolabeling with anti-Aß42 is deleted from A. Laminar distribution of neurofibrillary tangles is evident. Deposits of Aß40 are rare in the deep layers (asterisk), where deposits of Aß42 are numerous (A). Bars = 500 µm. (C) Higher magnification of A. Core-like structures (arrowheads) are positive for both Aß40 and Aß42, whereas large cotton wool plaques are mainly positive for Aß42 (arrows). Bar = 250 µm.

Figure 3. Triple immunofluorolabeling of the cerebral cortex with anti-Aß42 (blue), anti-Aß40 (green), and anti-PHF tau (red). Cotton wool plaques (asterisks) are positive mainly for Aß42, and participation of Aß40 is not detectable. Core-like structures (arrowheads) and blood vessel (arrow) are positive for Aß40 and for Aß42 to a lesser extent. Reactive neurites are slender and are clustered around CWPs but are not detectable around Aß40-positive structures. Bar = 100 µm.

Figure 4. A total of 114 optical sections (X–Y with the interval of 0.3 µm along Z-axis) were obtained from a triple-labeled thick floating section (green, Aß40; red, PHF-tau; blue, von Willebrand factor for blood vessels) from the cerebral cortex. Three-dimensional reconstruction was performed on the software. (A) Stacked image of the 114 optical sections (X–Y). Core-like structures (Aß40) were clustered along the blood vessel. (B) One of the optical sections (X–Y) at the depth indicated with white lines in C and D. (C) Cross-sectional Y–Z image along the yellow lines indicated in B and D. (D) Cross-sectional X–Z image along the red line indicated in B and C. (E) Cross-sectional image along the blood vessel indicated with a white arbitrary line in A with two extremities marked as arrowhead and asterisk. Focal deposition of Aß40 in the vessel wall was occasionally in continuity with core-like structures around the vessel wall. Bar = 50 µm.

Most of the CWPs were homogeneously labeled with the anti-Aß42 antibody [green in Fig 2 (arrows) and blue in Fig 3], and participation of Aß40 was partial on these CWPs (blue in Fig 2 and green in Fig 3). In contrast, Aß40 was deposited as core-like structures (arrowheads in Fig 2C and Fig 3), which were rare in deeper layers of the cerebral cortices (asterisk in Fig 2B, blue) and contained also Aß42 (arrowheads in Fig 2C). Three-dimensional analysis demonstrated that these core-like structures positive for Aß40 (Fig 4, green) were sometimes clustered along the blood vessel (arrowhead in Fig 4A). The Aß40 epitope was sometimes co-localized to the vessel wall, with an occasional continuity to these core-like structures. Neuritic reactions, detected with AT8/rhodamine, were present around CWPs (asterisks in Fig 3, red), but they were rarely observed around the core-like structures (arrowheads in Fig 3) or the vessel wall (arrow in Fig 3).

As suggested by the stacked view of the 114 optical sections (Fig 4A), some of the core-like structures were occasionally clustered around blood vessels. Three-dimensional observation with the software enabled us to examine a simultaneous stereoscopic view of these three epitopes (Aß40, PHF-tau, and blood vessel). Finally, a cross-sectional view along an arbitrary cutting line on the blood vessel (from arrowhead to asterisk in Fig 4) showed that Aß40 accumulated around the blood vessel either in a linear or a spherical fashion (Fig 4E).


  Discussion
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

We successfully performed triple immunofluorolabeling with two antibodies raised in rabbits and another mouse MAb. Single immunofluorolabeling with different concentrations of the anti-Aß40 antibody clarified that the optimal dilution of the anti-Aß antibodies without CARD amplification was 1:1000, whereas equivalent labeling was obtained at a dilution of 1:30,000 after amplification with CARD. One of the theoretical bases for discriminating two distinct epitopes with antibodies raised in the same species depends on this difference in the optimal concentration of the antibody for immunofluorescence study (Hunyady et al. 1996 ). The anti-Aß40 antibody in the first cycle was so diluted (1:30,000) that the corresponding epitope could be visualized only after the amplification, but visualization without amplification, as used in the second cycle, was not sensitive enough to detect this anti-Aß40 antibody diluted further to another 30-fold below the detection threshold. It is possible that the anti-rabbit antibody used in the first cycle before CARD amplification could be a source of crossreaction because it has an affinity for the other polyclonal antibody produced also in rabbit used in the second cycle. Practically, this reaction was found to be less than the detection threshold, as demonstrated in Fig 2, which showed definite separation of the signals from Aß40 and Aß42 epitopes. Specific labelings were perfectly interchangeable when the two antibodies, anti-Aß40 and anti-Aß42, were replaced with each other (Fig 3), which provided additional evidence that crossreaction between the two epitopes was negligible. The absence of crossreaction may be explained by the low concentration of the first primary antibody, which attracts, if any, a very tiny amount of the anti-rabbit antibody. This amount of the anti-rabbit antibody should be far below the detection threshold even if the second polyclonal antibody is attached to it. Wide separation of the emission signals from FITC and from Cy5 made it possible to insert another emission signal from rhodamine without crosstalk between them (Table 2), because rhodamine was designed to label another monoclonal antibody, AT8, through anti-mouse IgG, which never crossreacts with the other two polyclonal antibodies produced in rabbits.

These triple-labeled sections demonstrated that most of the CWPs were homogeneously stained with the anti-Aß42 antibody (Crook et al. 1998 ; Le et al. 2001 ; Steiner et al. 2001 ; Verkkoniemi et al. 2001 ; Tabira et al. 2002 ). One of the intriguing findings was that core-like structures were intensely labeled with the anti-Aß40 antibody. These core-like structures were rare in deeper cortical layers of the cerebral cortex (Fig 2B) and were not necessarily associated with deposits of Aß42. Although a possible spatial relationship of these core-like structures to blood vessels was suspected even with two-dimensional observation (Fig 3), 3D reconstruction confirmed that they were sometimes in continuity with blood vessels similarly labeled with the anti-Aß40 antibody (Fig 4). Furthermore, this reconstruction enabled us to observe cross-sectional images not only along the X, Y, or Z axis but also along an arbitrary line tracing the target structure, e.g., blood vessels as shown in Fig 4E. No similar relationship to blood vessels was evident with Aß42-positive CWPs. Simultaneous labeling with AT8/rhodamine demonstrated that AT8-positive neurites were slender, without focal swelling, and were abundant around CWPs but rarely associated with the core-like structures. Furthermore, AT8-positive structures were uniformly scattered throughout the entire thickness of the sections, providing proof that this triple immunofluorolabeling reliably and homogeneously detected the structures in question under the present experimental conditions applied to the thick sections. Morphology, immunohistochemical features, and association of tau-positive neurites were found to be different in Aß42-positive CWPs from those in Aß40-positive core-like structures and blood vessels. These differences suggest that mechanisms involved in Aß deposition may be different in these structures found in the same microscopic field.

In summary, we established a triple-immunofluorolabeling method with two rabbit polyclonal antibodies and a mouse monoclonal antibody, which simultaneously visualized Aß40, Aß42, or von Willebrand factor and PHF-tau epitopes. Application of this triple immunofluorolabeling enabled thick sections to be analyzed on a 3D basis. Immunohistochemical features and distribution were found to be different between Aß42-positive deposits and their Aß40-positive counterparts. This suggests that the mechanism of Aß deposition for CWPs is different from that of other Aß deposits, such as core-like structures. This triple-labeling method will expand the applicability and precision of multiple immunoflurolabeling, which is advantageous in a wide range of research and diagnosis.


  Acknowledgments

Supported in part by a grant (TU) from the Ministry of Culture, Sports, Science and Technology, Japan.

We are grateful to Mr Ray Cowan for reading the manuscript.

Received for publication November 5, 2002; accepted April 2, 2003.


  Literature Cited
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Adams JC (1992) Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains. J Histochem Cytochem 40:1457-1463[Abstract/Free Full Text]

Akiyama H, Mori H, Sahara N, Kondo H, Ikeda K, Nishimura T, Oda T et al. (1997) Variable deposition of amyloid ß-protein (Aß) with the carboxy-terminus that ends at residue valine 40 (Aß40) in the cerebral cortex of patients with Alzheimer's disease: a double-labeling immunohistochemical study with antibodies specific for Aß40 and the Aß that ends at residues alanine 42/threonine43 (Aß42). Neurochem Res 22:1499-1506[Medline]

Bobrow MN, Harris TD, Shaughnessy KJ, Litt GJ (1989) Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays. J Immunol Methods 125:279-285[Medline]

Crook R, Verkkoniemi A, Perez–Tur J, Mehta N, Baker M, Houlden H, Farrer M et al. (1998) A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nature Med 4:452-455[Medline]

Hunyady B, Krempels K, Harta G, Mezey E (1996) Immunohistochemical signal amplification by catalyzed reporter deposition and its amplification in double immunostaining. J Histochem Cytochem 44:1353-1362[Abstract]

Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y (1994) Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron 13:45-53[Medline]

Kitamoto T, Ogomori K, Tateishi J, Prusiner SB (1987) Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest 57:230-236[Medline]

Lan HY, David WM, Nikolic–Paterson DJ, Atkins RC (1995) A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody crossreactivity and retrieve antigens. J Histochem Cytochem 43:97-102[Abstract/Free Full Text]

Le TV, Crook R, Hardy J, Dickson DW (2001) Cotton wool plaques in non-familial late-onset Alzheimer disease. J Neuropathol Exp Neurol 60:1051-1061[Medline]

Lewis–Carl SAL, Gillete–Ferguson I, Ferguson DG (1993) An indirect immunofluorescence procedure for staining the same cryosection with two mouse monoclonal primary antibodies. J Histochem Cytochem 41:1273-1278[Abstract/Free Full Text]

Mercken M, Vandermeern M, Lübke U, Six J, Boons J, Van de Voorde A, Martin J-J et al. (1992) Monoclonal antibodies with selective specificity for Alzheimer tau are directed against phosphatase-sensitive epitopes. Acta Neuropathol (Berl) 84:265-272[Medline]

Nakane PK (1968) Simultaneous localization of multiple tissue antigens using the peroxidase labeled antibody method. A study on pituitary gland of the rat. J Histochem Cytochem 16:557-560[Medline]

Nakayama H, Arima K, Mizushima S, Chui DH, Tabira T (2001) An autopsy case of juvenile Alzheimer's disease with cotton wool plaques. Neuropathology 21(suppl):A32

Steiner H, Revesz T, Neumann M, Romig H, Grim MG, Pesold B, Kretzschmar HA et al. (2001) A pathogenic presenilin-1 deletion causes aberrant Aß42 production in the absence of congophilic amyloid plaques. J Biol Chem 276:7233-7239[Abstract/Free Full Text]

Tabira T, Chui DH, Nakayama H, Kuroda S, Shibuya M (2002) Alzheimer's disease with spastic paraparesis and cotton wool type plaques. J Neurosci Res 70:367-372[Medline]

Uchihara T, Kondo H, Akiyama H, Ikeda K (1995) Single-laser three-color immunolabeling of a histological section by laser scanning microscopy: application to senile-plaque related structures in postmortem human brain tissue. J Histochem Cytochem 43:103-106[Abstract/Free Full Text]

Uchihara T, Nakamura A, Nagaoka U, Yamazaki M, Mori O (2000) Dual enhancement of double immunofluorescent signals by CARD: participation of ubiquitin during formation of neurofibrillary tangles. Histochem Cell Biol 114:447-451[Medline]

Van der Loos CM, Das PK, Van den Oord JJ, Houthoff HJ (1989) Multiple immunoenzyme staining techniques. Use of fluoresceinated, biotinylated and unlabelled monoclonal antibodies. J Immunol Methods 117:45-52[Medline]

Verkkoniemi A, Kalimo H, Paetau A, Somer M, Iwatsubo T, Hardy J, Haltia M (2001) Variant Alzheimer disease with spastic paraparesis: neuropathological phenotype. J Neuropathol Exp Neurol 60:483-492[Medline]